Variations in the low levels of cyclin D1/BCL1 have prognostic value in chronic lymphocytic leukemia

Leukemia Research

Volumn 24, Issue 6, 2000, Pages 469-474

  Ravandi Kashani, Farhad ^a   O'Brien, Susan ^a   Manshouri, Taghi ^b   Lerner, Susan ^a   Sim, Sue ^b   Dodd, Kristi ^b   Kantarjian, Hagop ^a   Freireich, Emil ^a   Keating, Michael ^a   Albitar, Maher ^b  

^a UNIVERSITY OF TEXAS   (United States)

^b Division of Pathology and Laboratory Medicine   (United States)

Author keywords

BCL1; Chronic lymphocytic leukemia; CyD1; Cytogenetics; Prognosis

Indexed keywords

BETA 2 MICROGLOBULIN; CYCLIN D1; FLUDARABINE; HEMOGLOBIN;

ADULT; AGED; ARTICLE; CELL CYCLE G1 PHASE; CELL SURVIVAL; CHRONIC LYMPHATIC LEUKEMIA; DIAGNOSTIC VALUE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; CYCLIN D1; FEMALE; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC; MALE; MIDDLE AGED; MONOCYTES; PROGNOSIS; RADIOIMMUNOASSAY; SURVIVAL RATE;

EID: 0033995196     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(00)00008-4     Document Type: Article

References (26)

1. Hartwell L.H., Kastan M.B. Cell cycle control and cancer. Science. 266:1994;1821.
2. Donnellan R., Cherry R. Cyclin D1 and human neoplasia. Mol. Pathol. 51:1998;1.
3. Clurman B.E., Roberts J.M. Cell cycle and cancer. J. Natl. Cancer Inst. 87:1995;1499.
4. Bosch F., Jares P., Campo E., Lopez-Guillerno A., Piris M.A., Villamor N., Tassies D., Jaffe E.S., Montserrat E., Rosman C. PRAD-1/cyclin D1 gene overexpression in chronic myeloproliferative disorders: a highly specific marker for mantle cell lymphoma. Blood. 84:1994;2726.
5. Rimokh R., Berger F., Delsol G., Charrin C., Bertheas M.F., Ffrench M., Garoscio M., Felman P., Coiffier B., Bryon P.A. Rearrangement and overexpression of the bcl-1/PRAD-1 gene in intermediate lymphocytic lymphomas and in t(11q13)-bearing leukemias. Blood. 81:1993;3063.
6. Rosenberg C.L., Wong E., Pretty E.M., Bale A.E., Tsujimoto Y., Harris N.L., Arnold A. PRAD1, a candidate bcl1 oncogene: mapping and expression in centrocytic lymphoma. Proc. Natl. Acad. Sci. USA. 88:1991;9638.
7. De Boer C.J., Schuuring E., Dreef E., Peters G., Bartek J., Kluin P.M., van Krieken J.H. Cyclin D1 protein analysis in the diagnosis of mantle cell lymphoma. Blood. 86:1995;2715.
8. Oka K., Ohno T., Kita K., Yamaguchi M., Takakura N., Nishii K., Miwa H., Shirakawa S. PRAD1 gene over-expression in mantle cell lymphoma but not in other low grade B-cell lymphomas including extranodal lymphoma. Br. J. Haematol. 86:1994;786.
9. Erikson J., Finan J., Tsujimoto Y., Nowell P.C., Croce C.M. The chromosome 14 breakpoint in neoplastic B-cells with the t(11;14) translocation involves the immunoglobulin heavy chain locus. Proc. Natl. Acad. Sci. USA. 81:1984;4144.
10. Nowell P., Shankey T.V., Finan J., Guerry D., Besa E. Proliferation, differentiation, and cytogenetics of chronic leukemic B lymphocytes cultured with mitomycin treated normal cells. Blood. 57:1981;444.
11. Newman R.A., Peterson B., Davey F.R., Brabyn C., Collins H., Brunetto V.L., Duggan D.B., Weiss R.B., Royston I., Millard F.E., Miller A.A., Bloomfield C.D. Phenotypic markers and BCL-1 gene rearrangements in B-cell chronic lymphocytic leukemia: a Cancer and Leukemia Group B study. Blood. 82:1993;1239.
12. Juliusson G.J., Oscier D.G., Fitchett M., Ross F.M., Stockdill G., Mackie M.J., Parker A.C., Castoldi G.L., Cuneo A., Knuutila S., Elonen E., Gahrton G. Prognostic subgroups in B-cell chronic lymphocytic leukemia defined by specific chromosomal abnormalities. New Engl. J. Med. 323:1990;720.
13. Rimokh R., Berger F., Bastard C., Klein B., French M., Archimbaud E., Rouault J.P., Santa Lucia B., Duret L., Vuillaume M., Coiffier B., Bryon P.A., Magaud J.P. Rearrangement of CCND1 (BCL1/PRAD1) 3′ untranslated region in mantle cell lymphomas and t(11q13)-associated leukemias. Blood. 83:1994;3689.
14. Yang W.I., Zukerberg L.R., Motokura T., Arnold A., Harris N. Cyclin D1 (Bcl-1, PRAD1) protein expression in low-grade B-cell lymphomas and reactive hyperplasia. Am. J. Pathol. 145:1994;86.
15. Atassi M.Z., Dolimbek B.Z., Manshouri T. Antibody and T-cell recognition of alpha-bungarotoxin and its synthetic loop-peptides. Mol. Immunol. 32:1995;919.
16. Albitar M., Manshouri T., Kantarjian H., Keating M., Estrov Z., Faber J., Freireich E.J., Pierce S., Estey E. Correlation between lower c-mpl protein expression and favorable cytogenetic groups in acute myeloid leukemia. Leuk. Res. 23:1999;63.
17. Cheson B.D., Bennett J.M., Grever M., Kay N., Keating M.J., O'Brien S., Rai K.R. National Cancer Institute - sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood. 87:1996;4990.
18. Williams, M.E., Swerdlow, S.H., Rosenberg, C.L., Arnold, A., Nowell, P.C., Croce, C.M., 1992. Characterization of chromosome 11 translocation breakpoints at the bcl-1 and PRAD1 loci in centrocytic lymphoma. Cancer Res. 52, 5541s (suppl.).
19. Williams M.E., Meeker T.C., Swerdlow S.H. Rearrangement of the chromosome 11 bcl-1 locus in centrocytic lymphoma: analysis with multiple breakpoint probes. Blood. 78:1991;493.
20. Medeiros L.J., Van Krieken J.H., Jaffe E.S., Raffeld M. Association of bcl-1 rearrangements with lymphocytic lymphoma of intermediate differentiation. Blood. 76:1990;2086.
21. Raffeld, M., Jaffe, E.S., 1991. bcl-1, t(11;14), and mantle cell-derived lymphomas. Blood 78, 259 (editorial).
22. De Boer C.J., van Krieken J.H.J.M., Kluin-Nelemans H.C., Kluin P.M., Schuuring E. Cyclin D1 messenger RNA over-expression as a marker for mantle cell lymphoma. Oncogene. 10:1995;1833.
23. Aguilera N.S., Bijwaard K.E., Duncan B., Krafft A.E., Chu W.S., Abbondanzo S.L., Lichy J.H., Taubenberger J.K. Differential expression of cyclin D1 in mantle cell lymphoma and other non-Hodgkin's lymphomas. Am. J. Pathol. 153:1998;1969.
24. Rosenberg C.L., Motokura T., Kronenberg H.M., Arnold A. Coding sequence of the overexpressed transcript of the putative oncogene PRAD1/cyclin D1 in two primary human tumors. Oncogene. 8:1993;519.
25. Hall M., Peters G. Genetic alterations of cyclins, cyclin-dependent kinases, and cdk inhibitors in human cancer. Adv. Cancer Res. 68:1996;67.
26. Hosokawa Y., Suzuki R., Joh T., Maeda Y., Nakamura S., Kodera Y., Arnold A. A small deletion in the 3′-untranslated region of the cyclin D1/PRAD1/bcl-1 oncogene in a patient with chronic lymphocytic leukemia. Int. J. Cancer. 76:1998;791.